Jefferson Parish President Cynthia Lee Sheng hosted a webinar with the US Surgeon General for faith leaders in Jefferson Parish about The Fight Is In Us, a national coalition that helps people who have recently recovered from COVID-19 become heroes by donating blood plasma.
ABC Issues National Press Release Regarding COVID-19 Convalescent Plasma (CCP) & Blood Community Aligns with Joint CCP Statement
America’s Blood Centers (ABC) has distributed a national news release regarding the role that community blood centers are playing in the collection of CCP as part of the nation’s response efforts to COVID-19. Additionally, ABC, AABB, and the American Red Cross have developed a joint statement on CCP to align messaging at a national level. READ MORE
The AABB Interorganizational Task Force on Domestic Disasters and Acts of Terrorism issued the following statement regarding blood donation during the COVID-19 pandemic. READ MORE
“We Need People to Start Turning Out in Force to Give Blood”
FDA Urging People to Donate Blood as Coronavirus Fears Intensify
(Washington, DC – March 12, 2020) – “We need people to start turning out in force to give blood.” That urgent call-to-action coming from Peter Marks, M.D., Ph.D., director of the U.S. Food and Drug Administration’s (FDA) Center for Biologics Evaluation and Research, as fear about the coronavirus is keeping people from wanting to donate blood. READ MORE
The International Plasma and Fractionation Association (IPFA) is pleased to announce the fourth IPFA Asia Workshop on Plasma Quality and Supply. This workshop will build on the success of the meetings held in Taiwan in 2016, Indonesia in 2017 and Malaysia in 2018, which highlighted the importance of this topic for the region. These meetings attracted over 200 delegates from 30 countries.
Event Details can be downloaded below:
Immucor PreciseType™ HEA Test Becomes the First-Ever FDA-Approved Diagnostic for Molecular Typing of Donor and Recipient Red Blood Cells for Blood Transfusions
Addresses critical unmet needs in blood banking and transfusion medicine – a fast, FDA-approved way to generate critical genetic matching information necessary to:
- Prevent alloimmunization and reduce risk of painful and potentially life-threatening transfusion reactions for patients receiving transfusions of red blood cells (RBC)
- Identify and maximize appropriate use of donor blood containing rare antigens